Cited by 1,476MicroRNA in disease regulationExtracellular vesicles in diseaseBarrier Structure and Function Studies

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis

Open access

Zhou, Weiying, Fong, Miranda Y., Min, Yongfen, Somlo, George, Liu, Liang, Palomares, Melanie R., Yu, Yang, Chow, Amy, O’Connor, Sean Timothy Francis, Chin, Andrew R., Yen, Yun, Wang, Yafan, Marcusson, Eric G., Chu, Peiguo, Wu, Jun, Wu, Xiwei, Li, Arthur Xuejun, Li, Zhuo, Gao, Hanlin, Ren, Xiubao, Boldin, Mark P., Lin, Pengnian Charles, Wang, Shizhen Emily·2014·Cancer Cell

DOI 10.1016/j.ccr.2014.03.007PMC PMC4016197

Open this paper in CoChat — free account Open PDF

Abstract

Cancer-secreted microRNAs (miRNAs) are emerging mediators of cancer-host crosstalk. Here we show that miR-105, which is characteristically expressed and secreted by metastatic breast cancer cells, is a potent regulator of migration through targeting the tight junction protein ZO-1. In endothelial monolayers, exosome-mediated transfer of cancer-secreted miR-105 efficiently destroys tight junctions and the integrity of these natural barriers against metastasis. Overexpression of miR-105 in nonmetastatic cancer cells induces metastasis and vascular permeability in distant organs, whereas inhibition of miR-105 in highly metastatic tumors alleviates these effects. miR-105 can be detected in the circulation at the premetastatic stage, and its levels in the blood and tumor are associated with ZO-1 expression and metastatic progression in early-stage breast cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2014.03.007

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gerçel-Taylor, Ç. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,333
Retracted
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature reviews. Immunology · doi:10.1038/nri855 · Cited by 5,355
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature reviews. Cancer · doi:10.1038/nrc865 · Cited by 4,018

Flagged first, then by citations

Show all 62 references

Sorted by citations

Items 801–900 of 1,001

Polarized Secretion of Extracellular Vesicles by Mammary Epithelia
Chin, A. R., Yan, W., Cao, M., Liu, X., & Wang, S. E. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9402-6 · Cited by 24
The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics
Weston, W. W., Ganey, T. M., & Temple, H. T. (2019) · BioDrugs · doi:10.1007/s40259-019-00338-5 · Cited by 24
Long Intergenic Noncoding RNA 00261 Acts as a Tumor Suppressor in Non-Small Cell Lung Cancer via Regulating miR-105/FHL1 Axis
Wang, Z., Zhang, J., Yang, B. Y., Li, R., Jin, L., Wang, Z., Yu, H., Liu, C., Mao, Y., & You, Q. (2019) · Journal of Cancer · doi:10.7150/jca.32251 · Cited by 23
Selectively-Packaged Proteins in Breast Cancer Extracellular Vesicles Involved in Metastasis
Dalla, P. V., Santos, J., MILTHORPE, B. K., & Padula, M. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144990 · Cited by 23
Exosomal and Non-Exosomal MicroRNAs: New Kids on the Block for Cancer Therapy
Syed, S. N., & Brüne, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094493 · Cited by 25
Transforming growth factor-β-induced secretion of extracellular vesicles from oral cancer cells evokes endothelial barrier instability via endothelial-mesenchymal transition
Kobayashi, M., Fujiwara, K., Takahashi, K., Yoshioka, Y., Ochiya, T., Podyma‐Inoue, K. A., & Watabe, T. (2022) · Inflammation and Regeneration · doi:10.1186/s41232-022-00225-7 · Cited by 25
Molecular Mechanisms Driving the Formation of Brain Metastases
Campbell, B. K., Gao, Z., Corcoran, N. M., Stylli, S. S., & Hovens, C. M. (2022) · Cancers · doi:10.3390/cancers14194963 · Cited by 23
Cancer-associated Fibroblasts Communicate with Breast Tumor Cells Through Extracellular Vesicles in Tumor Development
Castillo-Sánchez, R., Schuind, A. C., Martinez-Ival, M., & Salazar, E. P. (2022) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221131647 · Cited by 26
Role of extracellular vesicles in cancer-specific interactions between tumour cells and the vasculature
Adnani, L., Spinelli, C., Tawil, N., & Rak, J. W. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.11.003 · Cited by 25
N-acetylglucosaminyltransferase-V (GnT-V)-enriched small extracellular vesicles mediate N-glycan remodeling in recipient cells
Hirata, T., Harada, Y., Hirosawa, K. M., Tokoro, Y., Suzuki, K. G. N., & Kizuka, Y. (2022) · iScience · doi:10.1016/j.isci.2022.105747 · Cited by 23
Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence
Deng, M., Wu, S., Huang, P., Liu, Y., Li, C. V., & Zheng, J. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100870 · Cited by 23
Extracellular Vesicles and Artificial Intelligence: Unique Weapons against Breast Cancer
Serretiello, E., Smimmo, A., Ballini, A., Parmeggiani, D., Agresti, M., Bassi, P., Moccia, G., Sciarra, A., Angelis, A. D., Monica, P. D., et al. (2024) · Applied Sciences · doi:10.3390/app14041639 · Cited by 25
Aspirin suppresses tumor cell-induced angiogenesis and their incongruity
Maity, G., Chakraborty, J., Ghosh, A., Haque, I., Banerjee, S., & Banerjee, S. K. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-018-00499-y · Cited by 24
Metastatic Niches and the Modulatory Contribution of Mesenchymal Stem Cells and Its Exosomes
Alvarez, M., Gutiérrez, L. M., Correa, A., Lazarowski, A., & Bolontrade, M. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081946 · Cited by 23
The potential of exosomes in regenerative medicine and in the diagnosis and therapies of neurodegenerative diseases and cancer
Odehnalová, N., Šandriková, V., Hromádka, R., Skaličková, M., Dytrych, P., Hoskovec, D., Kejík, Z., Hajduch, J., Vellieux, F. M. D., Vašáková, M., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1539714 · Cited by 28
Exosomes: Traversing the blood-brain barrier and their therapeutic potential in brain cancer
Zhang, X., Artz, N., Steindler, D. A., Hingtgen, S., & Satterlee, A. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189300 · Cited by 25
Retracted : MicroRNA‐105 promotes epithelial‐mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl‐1
Jin, X., Yu, Y., Zou, Q., Wang, M., Cui, Y., Xie, J., & Wang, Z. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27873 · Cited by 22
Retracted
Clinical relevance and functional significance of cell-free microRNA-1260b expression profiles in infiltrative myxofibrosarcoma
Morita, T., Fujiwara, T., Yoshida, A., Uotani, K., Kiyono, M., Yokoo, S., Hasei, J., Kunisada, T., & Ozaki, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-66120-8 · Cited by 24
miRNAs in the Regulation of Cancer Immune Response: Effect of miRNAs on Cancer Immunotherapy
Pottoo, F. H., Iqubal, A., Iqubal, M. K., Salahuddin, M., Rahman, J. U., Alhajri, N., & Shehadeh, M. (2021) · Cancers · doi:10.3390/cancers13236145 · Cited by 22
Extracellular Vesicles as Mediators of Therapy Resistance in the Breast Cancer Microenvironment
Samuels, M., Cilibrasi, C., Papanastasopoulos, P., & Giamas, G. (2022) · Biomolecules · doi:10.3390/biom12010132 · Cited by 23
Message in a Bottle: Endothelial Cell Regulation by Extracellular Vesicles
Palazzo, C., D’Alessio, A., & Tamagnone, L. (2022) · Cancers · doi:10.3390/cancers14081969 · Cited by 22
Microfluidic harvesting of breast cancer tumor spheroid-derived extracellular vesicles from immobilized microgels for single-vesicle analysis
Rima, X. Y., Zhang, J., Nguyen, L. T. H., Rajasuriyar, A., Yoon, M. J., Chiang, C., Walters, N. A., Kwak, K. J., Lee, L. J., & Reátegui, E. (2022) · Lab on a Chip · doi:10.1039/d1lc01053k · Cited by 20
The Exosome Journey: From Biogenesis to Regulation and Function in Cancers
Li, Y., Li, M., Li, B., Li, Y., Shen, T., & Zhao, B. (2022) · Journal of Oncology · doi:10.1155/2022/9356807 · Cited by 26
The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer
Bogaczyk, A., Zawlik, I., Zuzak, T., Kluz, M., Potocka, N., & Kluz, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411489 · Cited by 22
Hypoxia induced cellular and exosomal RPPH1 promotes breast cancer angiogenesis and metastasis through stabilizing the IGF2BP2/FGFR2 axis
Ning, W., Yang, J., Ni, R., Yin, Q., Zhang, M., Zhang, F., Yang, Y., Zhang, Y., Cao, M., Jin, L., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03213-y · Cited by 22
Special delivery: microRNA-200–containing extracellular vesicles provide metastatic message to distal tumor cells
Epstein, D. M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci79191 · Cited by 22
“Moreover, the potential of miR-200–containing EVs to serve as predictive and prognostic biomarkers in breast cancer (13, 14) and other tumor mediated transfer of RNA and oncogenes (8, 9) from donor tumor cells to recipient endothelial, hematopoietic, and stromal cells promotes tumor progression (10, 11).”
Extracellular vesicles in breast cancer drug resistance and their clinical application
Yu, S., Wei, Y., Xu, Y., Zhang, Y., Li, J., & Zhang, J. (2016) · Tumor Biology · doi:10.1007/s13277-015-4683-5 · Cited by 22
“A previous study reported that metastatic BCa cells secrete miR-105, a potent modulator of tumor cell migration that targets the tight junction protein ZO-1 and can be transferred into endothelial cells via EV secretion, which destroyed the monolayer endothelial barriers, elevated the permeability of blood vessels, an…”
Background
Apoptotic neuron-secreted HN12 inhibits cell apoptosis in Hirschsprung's disease
Du, C., Xie, H., Zang, R., Shen, Z., Li, H., Chen, P., Xu, X., Xia, Y., & Tang, W. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s114838 · Cited by 22
Development of a Novel Serum Exosomal MicroRNA Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma
Liu, T., Du, L., Wang, Y., Gao, S., Li, J., Li, P., Sun, Z., Binang, H. B., & Wang, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.573501 · Cited by 22
Blocking of targeted microRNAs from next-generation sequencing libraries
Roberts, B. S., Hardigan, A. A., Kirby, M. K., Fitz-Gerald, M. B., Wilcox, C. M., Kimberly, R. P., & Myers, R. M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv724 · Cited by 8
An integrated workflow for biomarker development using microRNAs in extracellular vesicles for cancer precision medicine
Chen, Y., Wu, T., Zhu, Z., Huang, H., Zhang, L. N., Goel, A., Yang, M., & Wang, X. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.011 · Cited by 21
Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems
Sun, Y., Li, Y., Shi, S., & Dong, C. (2021) · Molecules · doi:10.3390/molecules26092703 · Cited by 21
Nanoplasmonic Sensor Approaches for Sensitive Detection of Disease-Associated Exosomes
Amrollahi, P., Zheng, W., Monk, C. H., Li, C.-Z., & Hu, Y. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00113 · Cited by 22
Exosomes and ferroptosis: roles in tumour regulation and new cancer therapies
Shi, Y., Qiu, B., Huang, L., Lin, J., Li, Y., Ze, Y., Huang, C., & Yao, Y. (2022) · PeerJ · doi:10.7717/peerj.13238 · Cited by 23
Exosomal EphA2 promotes tumor metastasis of triple-negative breast cancer by damaging endothelial barrier
Liu, X., Li, Y., Chen, C., Dong, J., Zhou, J., Tong, D., Wang, L., Gao, X., & Kang, X. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-022-10194-3 · Cited by 21
Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
Terceiro, L. E. L., Ikeogu, N. M., de Lima, M. F., Edechi, C. A., Nickel, B. E., Fischer, G., Leygue, E., McManus, K. J., & Myal, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512034 · Cited by 23
The Emerging Roles of Exosomal miRNAs in Breast Cancer Progression and Potential Clinical Applications
Li, J., He, D., Bi, Y., & Liu, S. (2023) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s432750 · Cited by 21
“37 And in endothelial monolayers, BC-released miR-105 via exosome transfer essentially disrupted the completeness of these naturally formed barricades for blocking metastasis.”
Background
Biomarkers and experimental models for cancer immunology investigation
Xu, H., Jia, Z., Liu, F., Li, J., Huang, Y., Jiang, Y., Pu, P., Shang, T., Tang, P., Zhou, Y., et al. (2023) · MedComm · doi:10.1002/mco2.437 · Cited by 21
Exosomes derived from pulmonary metastatic sites enhance osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS
Yu, P., Han, Y., Meng, L., Tian, Y., Jin, Z., Luo, J. F., Han, C. Q., Xu, W., Kong, L., & Zhang, C. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.01.016 · Cited by 22
“S3B) 32 .”
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Lagerweij, T., Pérez-Lanzón, M., & Baglio, S. R. (2018) · Journal of Visualized Experiments · doi:10.3791/56932 · Cited by 21
Extracellular vesicles and ctDNA in lung cancer: biomarker sources and therapeutic applications
Huang, C.-L., Liu, S., Tong, X., & Fan, H. S. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3586-8 · Cited by 22
Small Extracellular Vesicles and Metastasis—Blame the Messenger
Seibold, T., Waldenmaier, M., Seufferlein, T. T. W., & Eiseler, T. (2021) · Cancers · doi:10.3390/cancers13174380 · Cited by 20
Intercellular Crosstalk Via Extracellular Vesicles in Tumor Milieu as Emerging Therapies for Cancer Progression
Pătraș, L., & Banciu, M. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190701143845 · Cited by 21
Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights
Sharma, M., Kumar, U., & Singh, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11231-6 · Cited by 20
“Exosomal miR-105 disrupt vascular endothelial barriers by targeting the tight junction protein ZO-1, enhancing vascular permeability & promoting metastasis [60].”
Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression
Bhatt, S., Kanoujia, J., Dhar, A. K., Arumugam, S., Silva, A., & Mishra, N. (2020) · Current Drug Targets · doi:10.2174/1389450121999201006193005 · Cited by 20
MicroRNAs as therapeutic targets in breast cancer metastasis
Pouya, F. D., Rasmi, Y., Gazouli, M., Zografos, E., & Nemati, M. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00999-2 · Cited by 20
Role of Tumor-Associated Neutrophils in the Molecular Carcinogenesis of the Lung
Taucher, E., Taucher, V., Fink‐Neuboeck, N., Lindenmann, J., & Smolle‐Jüttner, F. (2021) · Cancers · doi:10.3390/cancers13235972 · Cited by 20
Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer
Agostino, S. D., Vahabi, M., Turco, C., & Fontemaggi, G. (2022) · Non-Coding RNA · doi:10.3390/ncrna8010005 · Cited by 20
Exosomal lncRNA LINC01356 Derived From Brain Metastatic Nonsmall-Cell Lung Cancer Cells Remodels the Blood–Brain Barrier
Geng, S., Tu, S., Bai, Z., & Geng, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.825899 · Cited by 20
Extracellular vesicles derived from Wharton’s Jelly mesenchymal stem cells inhibit the tumor environment via the miR-125b/HIF1α signaling pathway
Chang, Y.-H., Khánh, V. C., Ngo, N.-H., Yamashita, T., Ye, X., Futamura, Y., Fukushige, M., Obata‐Yasuoka, M., Hamada, H., Osaka, M., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-17767-y · Cited by 20
Extracellular vesicles as a novel approach for breast cancer therapeutics
Lee, Y., Graham, P., & Li, Y. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.216036 · Cited by 19
The Brain Pre-Metastatic Niche: Biological and Technical Advancements
Geissler, M., Jia, W., Kiraz, E. N., Kulacz, I., Liu, X., Rombach, A., Prinz, V., Jussen, D., Kokkaliaris, K. D., Medyouf, H., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210055 · Cited by 21
Influence of Extracellular Vesicles on Lung Stromal Cells during Breast Cancer Metastasis
Patel, U., Susman, D., & Allan, A. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411801 · Cited by 20
Pathological and Therapeutic Significance of Tumor-Derived Extracellular Vesicles in Cancer Cell Migration and Metastasis
Liguori, G. L., & Kralj‐Iglič, V. (2023) · Cancers · doi:10.3390/cancers15184425 · Cited by 22
“EVs released by metastatic breast cancer cells carrying miR-105 cause a tight junction decrease in endothelial cells in correspondence with various organs, with a consequent systemic vascular leakiness promoting the extravasation of tumor cells and the formation of distant metastasis [111].”
Background
Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis
Mitchell, M. I., & Loudig, O. D. (2023) · Biomedicines · doi:10.3390/biomedicines11092534 · Cited by 22
“Indeed, miR-105 and miR-939 carried within EVs derived from metastatic breast cancer cells have been shown to increase vascular permeability, accelerating metastasis by facilitating colonization in new tissues [177,180].”
Exosomes as new generation vehicles for drug delivery systems
Dilsiz, N. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105562 · Cited by 21
Critical roles of miR-21 in promotions angiogenesis: friend or foe?
Saadh, M. J., Jasim, N. Y., Ahmed, M. H., Ballal, S., Kumar, A., Atteri, S., Vashishth, R., Rizaev, J. A., Alhili, A., Jawad, M. J., et al. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01600-7 · Cited by 27
“The higher level of permeability of the blood vessels in the tumor aids in cancer expansion and metastasis, allowing a constant supply of oxygen and nutrients to cancer cells, enabling the cells to spread more readily and (forming) the precursors to successful metastases [187].”
Evaluation of miRNA-expression and clinical tumour parameters in oral squamous cell carcinoma (OSCC)
Moratin, J., Hartmann, S., Brands, R. C., Brisam, M., Mutzbauer, G., Scholz, C. J., Seher, A., Müller-Richter, U. D. A., Kübler, A. C., & Linz, C. (2016) · Journal of Cranio-Maxillofacial Surgery · doi:10.1016/j.jcms.2016.04.017 · Cited by 20
Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma
Cui, Q., Vari, F., Cristino, A. S., Salomón, C., Rice, G. E., Sabdia, M. B., Guanzon, D., Palma, C., Mathew, M., Talaulikar, D., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26141 · Cited by 20
Exosome-transferred lncRNAs at the core of cancer bone lesions
Léveillé, N., & Baglio, S. R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.03.002 · Cited by 20
Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients
Visan, K. S., Lobb, R. J., Wen, S., Bedő, J., Lima, L. G., Krumeich, S., Palma, C., Ferguson, K., Green, B., Niland, C., et al. (2022) · Cancers · doi:10.3390/cancers14010257 · Cited by 21
Exosomes released from Shiga toxin 2a–treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells
Lee, K., Lee, J., Lee, P., Kim, C.-U., Kim, D., Jeong, Y., Park, Y., Tesh, V. L., & Lee, M. (2020) · Cellular Microbiology · doi:10.1111/cmi.13249 · Cited by 20
NSCLC Extracellular Vesicles Containing miR-374a-5p Promote Leptomeningeal Metastasis by Influencing Blood‒Brain Barrier Permeability
Jin, J., Cui, Y., Niu, H., Lin, Y., Wu, X., Qi, X., Bai, K., Zhang, Y., Wang, Y., & Bu, H. (2024) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-0052 · Cited by 19
“It was recently reported that exosome-mediated transfer of cancer cell–derived miR-105 into vascular endothelial cells promotes cancer progression by targeting ZO1 and effectively disrupting tight junctions and the integrity of the related natural barriers (36).”
Plant-derived extracellular vesicles as nanocarriers for combination therapy enhancing paclitaxel-based regimens in breast cancer
Song, Y., Kong, H., Oh, S., & Kim, S. B. (2025) · BMB Reports · doi:10.5483/bmbrep.2024-0193 · Cited by 21
“For example, miR-105 in breast cancer-derived EVs can inhibit the expression of the endothelial tight junction protein zonular occludens 1, thereby increasing vascular permeability and promoting metastatic spread (50, 51).”
Exosomal hsa-miR-933 in Gastric Juice as a Potential Biomarker for Functional Dyspepsia
Tanaka, F., Takashima, S., Nadatani, Y., Otani, K., Hosomi, S., Kamata, N., Taira, K., Nagami, Y., Tanigawa, T., Fukumoto, S., et al. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06096-7 · Cited by 19
Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?
Martino, V. D., Rossi, M., Battafarano, G., Pepe, J., Minisola, S., & Fattore, A. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212586 · Cited by 19
Significance of metastamiR-10b in breast cancer therapeutics
Raval, A. P., Joshi, J. S., & Shah, F. D. (2022) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-022-00120-9 · Cited by 19
Tumor-Derived Small Extracellular Vesicles Involved in Breast Cancer Progression and Drug Resistance
Feng, L., Guo, L., Tanaka, Y., & Su, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315236 · Cited by 19
Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells
Yi, Y. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043704 · Cited by 20
Exosome-derived Small RNAs in mouse Sertoli cells inhibit spermatogonial apoptosis
Gao, H., Cao, H., Li, Z., Li, L., Guo, Y., Chen, Y., Peng, G., Zeng, W., Du, J., Dong, W., et al. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.02.011 · Cited by 24
Hypoxic nasopharyngeal carcinoma‐derived exosomal miR‐455 increases vascular permeability by targeting ZO‐1 to promote metastasis
Xie, L., Zhang, K., You, B., Yin, H., Zhang, P., Shan, Y., Gu, Z., & Zhang, Q. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23525 · Cited by 21
Melatonin targeting non-coding RNAs in cancer: Focus on mechanisms and potential therapeutic targets
Mafi, A., Keshavarzmotamed, A., Hedayati, N., Boroujeni, Z. Y., Reiter, R. J., Dehmordi, R. M., Aarabi, M. H., Rezaee, M., & Asemi, Z. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175755 · Cited by 19
Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis
Arena, G. O., Forte, S., Abdouh, M., Vanier, C. H., Corbeil, D., & Lorico, A. (2023) · Cells · doi:10.3390/cells12121566 · Cited by 18
Profiling the polyadenylated transcriptome of extracellular vesicles with long-read nanopore sequencing
Padilla, J.-C. A., Barutcu, S., Malet, L., Deschamps-Francoeur, G., Calderon, V., Kwon, E., & Lécuyer, É. (2023) · BMC Genomics · doi:10.1186/s12864-023-09552-6 · Cited by 20
“Indeed, the implications are wide ranging, from the promotion of tumorigenesis [16–18], to increased drug resistance in cancer [19–21].”
Background
Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome
Wood, L. W., Cox, N. I., Phelps, C. A., Lai, S., Poddar, A., Talbot, C. C., & Mu, D. (2016) · Scientific Reports · doi:10.1038/srep19857 · Cited by 20
Suppressive effect of an analog of the antimicrobial peptide of LL‑37 on colon cancer cells via exosome‑encapsulated miRNAs
Hayashi, M., Kuroda, K., Ihara, K., Iwaya, T., & Isogai, E. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3875 · Cited by 19
“Several studies have suggested that exosomes secreted by cancer cells assist in cancer growth and angiogenesis, leading to cancer metastasis (15,36).”
The role of exosomal shuttle RNA (esRNA) in lymphoma
Li, J., Tian, T., & Zhou, X. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.013 · Cited by 18
Exosomal miRNA: an alternative mediator of cell-to-cell communication
Li, J., Jiang, X., & Wang, K. (2019) · ExRNA · doi:10.1186/s41544-019-0025-x · Cited by 20
Exosomes: Dynamic Mediators of Extracellular Communication in the Tumor Microenvironment.
Wolf-Dennen, K., & Kleinerman, E. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-43085-6_13 · Cited by 16
Extracellular Vesicles in Cancer Drug Resistance: Implications on Melanoma Therapy
Musi, A., & Bongiovanni, L. (2023) · Cancers · doi:10.3390/cancers15041074 · Cited by 18
Towards the realization of clinical extracellular vesicle diagnostics: challenges and opportunities
Yokoi, A., Yoshioka, Y., & Ochiya, T. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1104249 · Cited by 19
Extracellular Vesicles from Caveolin-Enriched Microdomains Regulate Hyaluronan-Mediated Sustained Vascular Integrity
Mirzapoiazova, T., Lennon, F. E., Mambetsariev, B., Allen, M., Riehm, J., Poroyko, V. A., & Singleton, P. A. (2015) · International Journal of Cell Biology · doi:10.1155/2015/481493 · Cited by 18
Identification of low miR-105 expression as a novel poor prognostic predictor for human glioma.
Guan, Y., Chen, L., Bao, Y., Li, Z., Cui, R., Li, G., & Wang, Y. (2015) · PubMed Central · Cited by 18
Soluble fms‐like tyrosine kinase‐1‐enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration
Hao, D., Li, Y., Zhao, G.-F., & Zhang, M. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.13175 · Cited by 18
Exosomes in head and neck cancer. Updating and revisiting
Zorrilla, S. R., Garcı́a, A. G., Carrión, A. B., Vila, P. G., Martín, J. M. S., Gallas, M., & Pérez‐Sayáns, M. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1662000 · Cited by 18
miR-452 promotes the development of gastric cancer via targeting EPB41L3
He, X., & Shu, Y. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152725 · Cited by 18
Purification Methods and the Presence of RNA in Virus Particles and Extracellular Vesicles
Zhou, Y., McNamara, R. P., & Dittmer, D. P. (2020) · Viruses · doi:10.3390/v12090917 · Cited by 18
MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases
Matsuda, A., Yan, I. K., Foye, C., Parasramka, M. A., & Patel, T. C. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.07.005 · Cited by 20
Prostate cancer exosomes as modulators of the tumor microenvironment
Shephard, A. P., Yeung, V., Clayton, A., & Webber, J. P. (2017) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2017.32 · Cited by 19
“Metastatic breast cancer cells, for example, were shown to enhance vascular permeability, and promote tumor metastasis, via the suppression of the tight junction protein ZO-1 by exosome delivered miR105[70].”
Background
microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers
Saumet, A., & Lecellier, C. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_2 · Cited by 17
Exosomes: A rising star in breast cancer (Review)
Wang, L., Wang, B., Wen, H., Mao, J., Ren, Y., & Yang, H. (2020) · Oncology Reports · doi:10.3892/or.2020.7638 · Cited by 16
Organ-Specific Uptake of Extracellular Vesicles Secreted by Urological Cancer Cells
Linxweiler, J., Kolbinger, A., Himbert, D., Zeuschner, P., Saar, M., Stöckle, M., & Junker, K. (2021) · Cancers · doi:10.3390/cancers13194937 · Cited by 17
Extracellular vesicles: from bench to bedside
Chen, Y., & Yu, L. (2022) · Current Medicine · doi:10.1007/s44194-022-00001-2 · Cited by 16
Exosomes from LSD1 knockdown breast cancer cells activate osteoclastogenesis and inhibit osteoblastogenesis
Liu, Z., Zhang, N., Xin, B., Shi, Y., Liang, Z., Wan, Y., & Hu, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123792 · Cited by 17
Exosomal miRNAs as novel avenues for breast cancer treatment
Singh, T., Kaushik, M. C., Mishra, L. C., Behl, C., Singh, V. P., & Tuli, H. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1134779 · Cited by 17
Unraveling the Role of EV-Derived miR-150-5p in Prostate Cancer Metastasis and Its Association with High-Grade Gleason Scores: Implications for Diagnosis
Cruz-Burgos, M., Cortés-Ramírez, S. A., Losada-García, A., Morales-Pacheco, M., Martínez‐Martínez, E., Morales-Montor, J. G., Haddad-Servín, A., Izquierdo-Luna, J. S., Martinez, G. R., Ramos‐Godínez, M. D. P., et al. (2023) · Cancers · doi:10.3390/cancers15164148 · Cited by 17
Potential roles of the exosome/microRNA axis in breast cancer
Mamalo, A. S., Alivirdiloo, V., Sadeghnejad, A., Hajiabbasi, M., Gargari, M. K., & Valilo, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154845 · Cited by 17
Exosome‐derived miR ‐182‐5p promoted cholangiocarcinoma progression and vasculogenesis by regulating ADK / SEMA5a / PI3K pathway
Wang, J., Jiang, W., Liu, S., Shi, K., Zhang, Y., Chen, Y., Shan, J., Wang, Y., Xu, X., Li, C. X., et al. (2023) · Liver International · doi:10.1111/liv.15773 · Cited by 17
“15,16 22 Nevertheless, there is a lack of relevant studies to confirm that exosomes derived from CCA can affect the progression of tumour.”
Background
Circulating Tumour Cells in the Prediction of Bone Metastasis
Choi, S. W., Sun, A. K., Cheung, J. P. Y., & Ho, J. C. Y. (2024) · Cancers · doi:10.3390/cancers16020252 · Cited by 17
“Circulating tumour cells (from breast tumours), on their part have been shown to secrete angiogenic factors and microRNA-105, both of which can decrease the expression of tight junction proteins of the vascular endothelial layer [27].”
Background
The role of microRNAs in brain metastasis
Hudson, K., Mondia, M. W. L., Zhang, Y., Saha, S., Gibert, M. K., Dube, C., Sun, Y., Marcinkiewicz, P., Fadul, C. E., & Abounader, R. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04541-x · Cited by 16
“Lastly, miR-105 was shown to directly target ZO-1, an important tight junction protein, in breast cancer BM [50].”
Background

Authors: Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., Yen, Y., Wang, Y., Marcusson, E. G., Chu, P., Wu, J., Wu, X., Li, A. X., Li, Z., Gao, H., Ren, X., Boldin, M. P., Lin, P. C., & Wang, S. E.
Affiliations: City Of Hope National Medical Center (US)
National Cancer Institute (US)
Regulus Therapeutics (United States) (US)
Tianjin Medical University Cancer Institute and Hospital (CN)
Corresponding author: Wang, Shizhen Emily
ORCID: Zhou, Weiying
Liu, Liang
Palomares, Melanie R.
Yu, Yang
Chow, Amy
Yen, Yun
Wang, Yafan
Marcusson, Eric G.
Wu, Jun
Wu, Xiwei
Li, Zhuo
Gao, Hanlin
Ren, Xiubao
Boldin, Mark P.
Wang, Shizhen Emily
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2014-04
Volume: 25
Issue: 4
Pages: 501-515
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2014.03.007
PMC: PMC4016197
OpenAlex: W2143839116
Cited by: 1,476
References: 62
Citations by year: 2026: 61 · 2025: 91 · 2024: 113 · 2023: 145 · 2022: 164 · 2021: 175 · 2020: 148 · 2019: 152 · 2018: 118 · 2017: 111 · 2016: 97 · 2015: 72 · 2014: 28
FWCI: 32.89
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 378 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: American Association for Cancer Research
Breast Cancer Research Foundation (12-60-26-WANG)
Celgene
National Institutes of Health
National Key Research and Development Program of China (2012CB9333004)
National Cancer Institute (P30CA-33572, R01CA166020, R01CA163586, P30CA033572)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords: miR-105, metastasis, breast cancer, ZO-1, tight junctions, endothelial barrier integrity, exosomes, vascular permeability, metastatic progression
MeSH terms: Breast Neoplasms, Cell Movement, Endothelium, Vascular, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, MicroRNAs, Cell Line, Tumor, Cell Growth Processes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks